info@marketresearchfuture.com   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)
Certified Global Research Member
Isomar 1 Iso 1
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

GCC Percutaneous Coronary Intervention Market Research Report By Product Type (Coronary Stents, Ballon Catheters, Coronary Guidewires, Guiding Catheters, Guiding Sheaths, Diagnostic Catheters, Crossing Catheters, Inflation Device, Guidance System, Peripheral Thrombectomy System, Embolic Protection System, Accessories), By Vascular Access (Radial, Femoral) and By End User (Hospitals Clinics, Ambulatory Surgical Centers, Others)- Forecast to 2035


ID: MRFR/HC/43697-HCR | 200 Pages | Author: Rahul Gotadki| March 2025

GCC Percutaneous Coronary Intervention Market Overview


As per MRFR analysis, the GCC Percutaneous Coronary Intervention Market Size was estimated at 372.17 (USD Million) in 2023.The GCC Percutaneous Coronary Intervention Market is expected to grow from 540.8(USD Million) in 2024 to 1,522.4 (USD Million) by 2035. The GCC Percutaneous Coronary Intervention Market CAGR (growth rate) is expected to be around 9.866% during the forecast period (2025 - 2035)


Key GCC Percutaneous Coronary Intervention Market Trends Highlighted


Numerous variables are driving many noteworthy trends in the GCC percutaneous coronary intervention market. The rising incidence of cardiovascular disorders in the area is one of the main factors propelling the market.Advanced treatment options like percutaneous coronary procedures are in higher demand as a result of the development of lifestyle-related illnesses like obesity and diabetes, especially in Saudi Arabia and the United Arab Emirates.


The market expansion is also aided by government programs aimed at enhancing the GCC's healthcare accessibility and infrastructure. The development of cutting-edge cardiac facilities is facilitated by the implementation of health-focused programs by GCC health ministries, which expands the potential for percutaneous interventions.The GCC industry is plenty with opportunities, especially given how quickly medical procedures and devices are developing technologically. New developments in catheter designs and stenting methods offer opportunities for better patient outcomes and increased effectiveness.


Collaborations between technology businesses and healthcare providers are encouraged by the region's growing emphasis on research and development, which could result in the launch of ground-breaking solutions. Additionally, public education and knowledge of heart health might result in prompt interventions, creating a favorable environment for market growth.Recent trends indicate a move toward minimally invasive procedures because of the advantages they offer, such as quicker recovery and less hospital stays. These procedures are being adopted by hospitals in the area, indicating that patients are increasingly choosing less intrusive treatments.


Furthermore, the growth of medical tourism in GCC nations, which is aided by the establishment of all-inclusive healthcare systems, provides opportunities for foreign patients in need of percutaneous coronary procedures, underscoring the market's vitality.


GCC Percutaneous Coronary Intervention Market size


Source: Primary Research, Secondary Research, MRFR Database and Analyst Review


GCC Percutaneous Coronary Intervention Market Drivers


Rising Prevalence of Cardiovascular Diseases


The GCC region has witnessed a significant rise in cardiovascular disease cases attributed to lifestyle changes, unhealthy dietary habits, and rising obesity rates. According to the World Health Organization, cardiovascular diseases account for approximately 33% of all deaths in the Middle East, with the GCC countries reporting projected increases in heart disease cases.


For instance, the Qatar National Health Strategy 2023-2022 highlights that cardiovascular diseases represent a leading health challenge in the region. Consequently, this surge in cardiovascular diseases is shaping the GCC Percutaneous Coronary Intervention Market, increasing the demand for innovative intervention procedures that can effectively treat these conditions.


Advancements in Medical Technology


Technological advancements have been pivotal in transforming the landscape of the GCC Percutaneous Coronary Intervention Market. The introduction of sophisticated catheter-based devices, minimally invasive techniques, and new imaging technologies have significantly improved the success rates of PCI procedures.


According to the Saudi Food and Drug Authority, recent regulatory approvals for advanced medical devices, including bioresorbable stents and innovative coronary angioplasty systems, are anticipated to drive market growth as hospitals in the region adopt these enhancements.


This technological evolution not only improves patient outcomes but also encourages health authorities and healthcare providers to invest more in PCI facilities and training, thus positively impacting the market.


Government Initiatives and Healthcare Spending


Government funding and initiatives across the GCC countries are pivotal in bolstering the healthcare sector, including percutaneous coronary interventions.According to the UAE Vision 2021, the government aims to enhance healthcare accessibility and quality through significant investments in medical infrastructure. This commitment is further reflected in initiatives like the Saudi Vision 2030, which aims to improve healthcare facilities and expand access to treatment for cardiovascular diseases.


Increased healthcare spending in the GCC region drives the growth of the GCC Percutaneous Coronary Intervention Market as more hospitals upgrade their facilities and incorporate advanced PCI technologies to cater to the growing population.


Rising Health Awareness and Preventative Measures


There has been a marked increase in health awareness and preventive healthcare measures among the GCC population, leading to early diagnosis and treatment of cardiovascular diseases. Campaigns led by organizations such as the Abu Dhabi Public Health Center focus on preventive healthcare, including regular health check-ups and awareness regarding the risks of heart disease.


This cultural shift towards proactive health management leads to a heightened demand for percutaneous coronary intervention services as individuals are more inclined to seek treatment for early warning signs of cardiovascular issues. As a result, the GCC Percutaneous Coronary Intervention Market is set to expand in response to this heightened health consciousness.


GCC Percutaneous Coronary Intervention Market Segment Insights


Percutaneous Coronary Intervention Market Product Type Insights


The GCC Percutaneous Coronary Intervention Market showcases a diverse range of product types that are pivotal to modern cardiovascular treatments. Among these, Coronary Stents play a crucial role in providing vessel support and facilitating blood flow, thus significantly impacting patient outcomes.Ballon Catheters are essential for performing angioplasty, allowing for the effective widening of narrowed or obstructed arteries, while Coronary Guidewires are vital for navigating through complex vascular anatomy, ensuring precise placement of interventional devices.


Guiding Catheters and Guiding Sheaths provide necessary access and stability for various procedures, making them integral components in the PCI toolkit. Diagnostic Catheters serve essential functions in assessing coronary artery conditions while Crossing Catheters enhance the ability to overcome blockages encountered during interventions.


The Inflation Device is significant for deploying stents and balloons effectively, while the Guidance System aids in visualization and navigation, thus enhancing procedural success rates. The Peripheral Thrombectomy System and Embolic Protection System are specialized devices designed to manage and mitigate complications during interventions.


Lastly, Accessories inclusive of support equipment and tools are indispensable in optimizing procedural efficiency and safety. Each of these product types contributes to the overall efficacy and safety of percutaneous coronary interventions in the GCC, where cardiovascular diseases are a leading health concern, highlighting the need for advanced medical technology and innovation.


The evolution of these product types reflects the ongoing trends in healthcare towards minimally invasive procedures and the increasing demand for effective coronary interventions.As the GCC health sector continues to grow, driven by investments in healthcare infrastructure and technology, the significance of these product types remains paramount in addressing the rising incidence of cardiovascular diseases across the region.


GCC Percutaneous Coronary Intervention Market Segment


Source: Primary Research, Secondary Research, MRFR Database and Analyst Review


Percutaneous Coronary Intervention Market Vascular Access Insights


The Vascular Access segment within the GCC Percutaneous Coronary Intervention Market plays a crucial role in ensuring effective patient outcomes during cardiac procedures. This segment caters primarily to two methods: Radial and Femoral access, both of which are vital in facilitating catheter-based interventions.Radial access has gained significant traction due to its advantages, such as reduced bleeding complications and quicker patient recovery times, making it a preferred choice among healthcare professionals in the GCC region.


In contrast, Femoral access remains significant due to its proven reliability in complex cases, showcasing the diverse needs of patients undergoing percutaneous coronary interventions. The GCC has made notable advancements in healthcare technology, which is reflected in the increasing adoption of innovative vascular access devices.


Furthermore, with a rise in cardiovascular diseases and the growing elderly population, there is an evident demand for effective vascular access solutions.


This evolving landscape opens up opportunities for market growth as providers look to enhance the efficiency and safety of cardiac procedures within the region. The nuances of the Vascular Access segment highlight its essentiality in the larger context of the GCC Percutaneous Coronary Intervention Market.


Percutaneous Coronary Intervention Market End User Insights


The GCC Percutaneous Coronary Intervention Market, particularly within the End User segment, plays a crucial role in the healthcare landscape, demonstrating the adaptability of advanced medical technologies across various healthcare environments.Hospitals and clinics have emerged as significant contributors to this market due to their comprehensive range of services and access to a larger patient base, thus facilitating an increased demand for percutaneous coronary interventions.


Ambulatory Surgical Centers, on the other hand, have gained traction as they offer a cost-effective alternative for outpatient procedures, catering to the growing trend of minimally invasive interventions that require shorter recovery times.


Meanwhile, the Others category captures additional healthcare facilities that participate in the percutaneous coronary intervention landscape but may not fall within the traditional designations, supporting innovation in treatment protocols.Factors driving growth in this segment include the rising prevalence of cardiovascular diseases in the GCC region and ongoing investments in healthcare infrastructure, aligning with national health strategies focused on improving patient outcomes.As healthcare providers continue to prioritize the quality of care, the dynamism of the End User segment is set to expand, answering the pressing need for effective cardiac interventions in the region.


GCC Percutaneous Coronary Intervention Market Key Players and Competitive Insights


The GCC Percutaneous Coronary Intervention Market is characterized by its dynamic landscape and increasing demand for advanced cardiovascular interventions, driven by a growing prevalence of coronary artery diseases and a rising aging population.As healthcare systems in the Gulf Cooperation Council region continuously evolve, the market is witnessing intensified competition among key players aiming to enhance their offerings through innovative technologies, improved patient care, and strategic partnerships.


Players are focused on expanding their product portfolios while navigating regulatory frameworks, fostering collaborations, and investing in research and development to maintain a competitive edge in this promising sector.


Merit Medical has established a notable presence within the GCC Percutaneous Coronary Intervention Market by focusing on high-quality medical devices and solutions tailored for cardiovascular procedures. The company’s strengths lie in its robust portfolio that includes essential accessories and devices such as guidewires, catheters, and delivery systems specifically designed for percutaneous interventions.


Merit Medical emphasizes its commitment to quality and innovation, allowing it to foster trust within the healthcare community and build lasting relationships with healthcare professionals.The company has strategically positioned itself through partnerships and collaborations, enhancing its distribution channels across the GCC region and ensuring a reliable supply chain to meet the growing demands of healthcare providers seeking advanced solutions for their patients.


Cardinal Health operates effectively within the GCC Percutaneous Coronary Intervention Market, focusing on delivering a wide range of medical products and services aimed at improving patient outcomes in cardiovascular care.The company boasts a diverse product offering, including cardiac catheters, imaging systems, and procedural kits, which cater specifically to the unique needs of the GCC healthcare landscape. Cardinal Health's market presence is bolstered by its reputation for reliability and innovation, making it a preferred choice among healthcare providers in the region.


The company actively invests in mergers and acquisitions to enhance its capabilities and expand its footprint in the GCC healthcare market, ensuring it can provide an integrated approach to cardiac care and maintain a competitive stride amidst growing regional demands.With a keen understanding of local market needs, Cardinal Health utilizes strategic partnerships to strengthen its distribution networks and collaborates with healthcare professionals to ensure the effectiveness of its products and services across the GCC.


Key Companies in the GCC Percutaneous Coronary Intervention Market Include



  • Merit Medical

  • Cardinal Health

  • Johnson and Johnson

  • Boston Scientific

  • Siemens Healthineers

  • Inari Medical

  • Philips

  • C.R. Bard

  • B. Braun

  • Terumo

  • Asahi Intecc

  • Medtronic

  • Abbott

  • GE Healthcare

  • Cook Medical


GCC Percutaneous Coronary Intervention Market Developments


The GCC Percutaneous Coronary Intervention Market has seen notable developments recently, with increasing investments by major companies such as Boston Scientific and Medtronic aiming to expand their product lines and services across the region.In October 2023, Merit Medical reinforced its presence in the UAE by launching advanced catheter products, responding to the growing demand for innovative cardiovascular solutions.


Additionally, Siemens Healthineers announced a collaboration in August 2023 with local healthcare providers to improve cardiac care infrastructure, aligning with the GCC's vision for enhanced medical technology adoption.While no recent mergers or acquisitions specifically among the targeted companies have been registered in the GCC, the market is generally buoyed by a robust growth trajectory, projected to reflect an increasing valuation as healthcare systems integrate newer technologies.


Moreover, the region's focus on healthcare improvement as part of broader economic diversification strategies has prompted key players like Philips and GE Healthcare to enhance their presence, targeting a rise in market valuation attributed to an uptick in procedural volumes.


Over the last two years, GCC countries have emphasized strengthening cardiac care as a priority, evident through institutional funding and initiatives, marking a significant shift in health policy towards interventional cardiology advancements.


GCC Percutaneous Coronary Intervention Market Segmentation Insights



  • Percutaneous Coronary Intervention Market Product Type Outlook

    • Coronary Stents

    • Ballon Catheters

    • Coronary Guidewires

    • Guiding Catheters

    • Guiding Sheaths

    • Diagnostic Catheters

    • Crossing Catheters

    • Inflation Device

    • Guidance System

    • Peripheral Thrombectomy System

    • Embolic Protection System

    • Accessories



  • Percutaneous Coronary Intervention Market Vascular Access Outlook

    • Radial

    • Femoral



  • Percutaneous Coronary Intervention Market End User Outlook

    • HospitalsClinics

    • Ambulatory Surgical Centers

    • Others



Report Attribute/Metric Source: Details
MARKET SIZE 2023 372.17(USD Million)
MARKET SIZE 2024 540.8(USD Million)
MARKET SIZE 2035 1522.4(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 9.866% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
MARKET FORECAST PERIOD 2025 - 2035
HISTORICAL DATA 2019 - 2024
MARKET FORECAST UNITS USD Million
KEY COMPANIES PROFILED Merit Medical, Cardinal Health, Johnson and Johnson, Boston Scientific, Siemens Healthineers, Inari Medical, Philips, C.R. Bard, B. Braun, Terumo, Asahi Intecc, Medtronic, Abbott, GE Healthcare, Cook Medical
SEGMENTS COVERED Product Type, Vascular Access, End User
KEY MARKET OPPORTUNITIES Increasing prevalence of coronary artery disease, Rising elderly population, Advancements in catheter technology, Growing healthcare expenditure, Expanding medical tourism in GCC.
KEY MARKET DYNAMICS rising cardiovascular diseases prevalence, increasing elderly population, advancements in catheter technology, growing healthcare expenditure, favorable reimbursement policies
COUNTRIES COVERED GCC


Frequently Asked Questions (FAQ) :

The GCC Percutaneous Coronary Intervention Market is expected to be valued at 540.8 USD Million in 2024.

By 2035, the GCC Percutaneous Coronary Intervention Market is projected to reach a value of 1522.4 USD Million.

The anticipated CAGR for the GCC Percutaneous Coronary Intervention Market from 2025 to 2035 is 9.866%.

Coronary Stents are projected to dominate the GCC Percutaneous Coronary Intervention Market with a value of 200.0 USD Million in 2024.

The market value for Balloon Catheters is expected to reach 350.0 USD Million by 2035.

Major players in the market include Johnson and Johnson, Boston Scientific, and Medtronic among others.

The expected market value for Coronary Guidewires in 2024 is 80.0 USD Million.

The market value of Guiding Sheaths is projected to reach 152.4 USD Million by 2035.

The market presents growth opportunities in advanced technologies and increasing cardiovascular disease prevalence.

The competitive landscape has evolved with significant advancements in product offerings by major players like Philips and Siemens Healthineers.

Leading companies partner with us for data-driven Insights.

clients

Kindly complete the form below to receive a free sample of this Report

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

report-img
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.